This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fincke, R. Search for Related Content PubMed PubMed Citation Articles by Fincke, R.

Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry

Rupert Fincke, MD^*,*, Judith S. Hochman, MD, FACC, April M. Lowe, MS, Venu Menon, MD, FACC, James N. Slater, MD, FACC, John G. Webb, MD, FACC^||, Thierry H. LeJemtel, MD, FACC^¶, Gad Cotter, MD, FACC^# SHOCK Investigators

^* New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, USA
New York University School of Medicine, New York, New York, USA
New England Research Institutes, Watertown, Massachusetts, USA
University of North Carolina, Chapel Hill, North Carolina, USA
^|| St. Paul's Hospital, Vancouver, Canada
^¶ Albert Einstein College of Medicine, Bronx, New York, USA
^# Duke University Medical Center, Durham, North Carolina, USA

View larger version (26K): [in a new window]   Figure 1 Time of hemodynamic measurements and right heart catheter (RHC) status of patients with left ventricular (LV) failure in the SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK (SHOCK) registry.

View larger version (13K): [in a new window]   Figure 2 Unadjusted estimated in-hospital mortality by cardiac power output (n = 189) with pointwise 95% confidence bands.